Breye Therapeutics ApS: Financial statements 2024
CVR: 40279865
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
Breye Therapeutics ApS (CVR 40279865) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,812,131 and a net result of DKK -70,150,057 compared with DKK -14,574,884 the year before. Equity in the 2024 report amounted to DKK 48,485,471. The solvency ratio was 79.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -7,812,131
- Profit/Loss
- DKK -70,150,057
- Equity
- DKK 48,485,471
- Total Assets
- DKK 60,681,859
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -7.8 mio. | -70.2 mio. | 48.5 mio. | 2 |
| 2023 | - | -2.9 mio. | -14.6 mio. | 14.5 mio. | 1 |
| 2022 | - | -674 t. | -780 t. | -752 t. | 1 |
| 2021 | - | -68 t. | -290 t. | 28 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 17, 2024, Novo Holdings A/S is registered as an owner of Breye Therapeutics ApS with an ownership share of 33%.
As of July 17, 2024, Visus Holding ApS is registered as an owner of Breye Therapeutics ApS with an ownership share of 10%.
As of July 17, 2024, is registered as an owner of Breye Therapeutics ApS with an ownership share of 5%.
About Breye Therapeutics ApS
Breye Therapeutics ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Ciana Therapeutics ApS and Visus Therapeutics ApS. The management consists of Ulrik Mouritzen. The board consists of Jimmy Arnold V Van Heusden (chair), Carl Johan Kördel, Chiara Rossana Maria Liberati and Gabriela Burian. The company's owners include Novo Holdings A/S, Visus Holding ApS and BII Holdings A/S. The company has 3 employees (2026). In 2026, the company reported a gross profit of DKK -7,655,438 and a net result of DKK -85,575,302 compared with DKK -89,139,846 the year before. Equity in the 2026 report amounted to DKK -126,213,092.